Avanir Pharmaceuticals (AVNR) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts AVNR Hot Sheet
Price: $16.96 --0%
Financial Fact:
Revenues from royalties: 178.79K
Today's EPS Names:
NSLR, OCTV, ACB, More
Financial Fact:
Revenues from royalties: 178.79K
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.29 million.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Four key things investors will watch in Nvidia's earnings next week
- BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
- Alpha Tau Medical Ltd. (DRTS) PT Raised to $16 at H.C. Wainwright
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
